Skip to main content

Table 2 Laboratory data at disease onset of KawaCOVID Group (KCG) and Kawasaki Disease Group (KDG)

From: Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey

  KCG (n = 53)
Median (IQR)
KDG(n = 96)
Median (IQR)
p value
Leucocytes (n/mmc) 11,500 (7310–15,830) 15,730 (11180–19,810) 0·003
Neutrophils (n/mmc) 9156 (6480–14,230) 10,617 (6000–14,780) 0·5
Lymphocytes (n/mmc) 940 (630–1570) 2790 (1680–4340) <·0001
Monocytes (n°/mmc) 320 (160–530) 960 (540–1390) <·0001
Hemoglobin (g/dL) 11,0 (10,1-11,8) 10,8 (10,0–11,7) 0·31
Platelets (n/mmc) 186,000 (132000–292,000) 402,500 (242000–523,000) <·0001
ALT (U/L) 27 (18–63) 29 (18–81) 1
AST (U/L) 36 (20–65) 30 (21–50) 0·56
GGT (U/L) 31 (16–67) 28 (13–59) 0·59
CRP (mg/L) 242 (138,5-300,5) 96,6 (40,6–195) <·0001
IgA (mg/dL) 134,5 (98–150) 83 (48,5-160,5) 0·17
IgG (mg/dL) 857 (655–857) 821 (600–1.106) 0·89
IgM (mg/dL) 90 (75–116) 98,5 (90–152,5) 0·31
Total protein (g/dL) 6 (5,2-6,7) 6,6 (5,9-7,1) 0·03
Albumin (g/dL) 2,9 (2,6-3,5) 3,4 (2,8-3,7) 0·05
CPK (U/L) 57 (32–136) 52 (33–117) 0·55
Troponin-T (ng/L) 82,5 (20–126) 3,5 (3–4) 0·002
Fibrinogen (mg/dL) 643 (515–740) 570,5 (468–714) 0·14
aPTT (ratio) 1,2 (1,0-1,3) 1,1 (1,0-1,2) 0·12
C3 (mg/dL) 139,5 (138–141) 138 (121–196) 0·89
C4 (mg/dL) 27,5 (22–33) 36 (24–46) 0·89
Ferritin (ng/mL) 563,8 (250–1.068) 227 (147–449) 0·0004
D-dimer (ng/mL) 2514 (1.380–3.890) 1740 (730–2.530) 0·03
NT-BNP (pg/mL) 927 (701–1.734) 347 (81–350) 0·08
ESR (mm/hr) 59 (36–81) 66,5 (49,5–98) 0·18
aPTT (sec) 31,7 (30,9-32,4) 26,9 (23–30) 0·16
PT (sec) 14,3 (13,2-15,2) 75,5 (55–88) 0·08
Troponin (ng/L) 168 (80–672) 4 (3–24) 0·001
Triglycerides (mg/dL) 217,5 (137–261) 144,5 (122–196) 0·04